Zamor, Philippe J <br/><br/>
Elbasvir/grazoprevir in black adults with hepatitis C virus infection: a pooled analysis of phase 2/3 clinical trials.  [electronic resource] 

 -  The American journal of gastroenterology  06 2018 
 - 863-871 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1572-0241 
<br/><br/><label>Standard No.: </label>10.1038/s41395-018-0053-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Black or African American--statistics & numerical data<br/>Aged<br/>Aged, 80 and over<br/>Antiviral Agents--therapeutic use<br/>Benzofurans--therapeutic use<br/>Clinical Trials, Phase II as Topic<br/>Clinical Trials, Phase III as Topic<br/>Drug Combinations<br/>Drug Therapy, Combination<br/>Female<br/>Genotype<br/>Hepacivirus--genetics<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Imidazoles--therapeutic use<br/>Male<br/>Middle Aged<br/>Quinoxalines--therapeutic use<br/>RNA, Viral--isolation & purification<br/>Retrospective Studies<br/>Ribavirin--therapeutic use<br/>Sustained Virologic Response<br/>Treatment Failure<br/>Young Adult